Showing results (41-50 of 257) with videos related to
Sort By:
Pageof 26
Frontiers in Oncology|March 19, 2020
A Bump in the Road: How the Hostile AML Microenvironment Affects CAR T Cell TherapyRebecca Epperly, Stephen Gottschalk, M Paulina VelasquezCytotherapy|June 13, 2021
Transient blockade of TBK1/IKKε allows efficient transduction of primary human natural killer cells with vesicular stomatitis virus G-pseudotyped lentiviral vectorsPeter Chockley, Sagar L Patil, Stephen GottschalkImmunity|August 20, 2020
Preventing Ubiquitination Improves CAR T Cell Therapy via 'CAR Merry-Go-Around'Nicole M Chapman, Stephen Gottschalk, Hongbo ChiChildren (Basel, Switzerland)|February 22, 2020
Harnessing T Cells to Target Pediatric Acute Myeloid Leukemia: CARs, BiTEs, and BeyondRebecca Epperly, Stephen Gottschalk, Mireya Paulina VelasquezImmunotherapy|December 1, 2012
Cancer-associated fibroblasts as targets for immunotherapySunitha Kakarla, Xiao-Tong Song, Stephen GottschalkTrends in Immunology|July 7, 2020
Rewriting History: Epigenetic Reprogramming of CD8+ T Cell Differentiation to Enhance ImmunotherapyCaitlin C Zebley, Stephen Gottschalk, Ben YoungbloodEuropean Journal of Medical Genetics|May 20, 2022
Dysmorphism and immunodeficiency - One of the differential diagnoses is PAX1 related otofaciocervical syndrome type 2Charlotte Sherlaw-Sturrock, Thomas Austin, Julia Baptista, et al.Molecular Therapy : the Journal of the American Society of Gene Therapy|October 17, 2012
T cells redirected to EphA2 for the immunotherapy of glioblastomaKevin K H Chow, Swati Naik, Sunitha Kakarla, et al.Leukemia & Lymphoma|December 29, 2004
Adoptive immunotherapy for EBV-associated malignanciesStephen Gottschalk, Helen E Heslop, Cliona M RooneyAnnual Review of Medicine|January 22, 2005
Post-transplant lymphoproliferative disordersStephen Gottschalk, Cliona M Rooney, Helen E HeslopPageof 26